Objective Response Rate Median Duration of Response Not Reached after 25 Months Follow UpLifileucel Launch in Previously Treated Advanced ...
Objective Response Rate Median Duration of Response Not Reached after 25 Months Follow Up Lifileucel Launch in Previously Treated Advanced NSCLC Expected in Second Half of 2027 SAN CARLOS, Calif.
London, UK, November 3, 2025 -- Blue Fin Vision, a leading provider of private eye care services, has announced a new benchmark in long-term refractive care: lifetime follow-up for all Implantable ...
In a significant step towards improving regional connectivity and providing faster travel options to the people here, the ...
A new study highlights the importance of Pap smear tests for early cervical cancer detection in India. It calls for better ...
Opportunities in the U.S. multiple myeloma market include leveraging cutting-edge therapies like targeted treatments and ...
Recent technological advances have opened new possibilities for neuroscience research, allowing researchers to map the brain's structure and synaptic connectivity (i.e., the junctions via which ...
Analysis - If you're reading this there's a good chance that you, like me, are a millennial. If so, you've probably noticed more and more cases of friends or acquaintances with diseases that you would ...
Nanlite updates its compact LED tube with the PavoTube II 6CP — brighter, longer lasting, and smarter with the Nebula C4 engine and App control.
Limited-production 1969 Chevrolet Camaro Hybrid Hypercar Project will feature all-carbon fiber bodywork, 1,300 HP twin-turbo V8 plus 300 HP electric motor providing highperformance all-wheel drive, ...
HUTCHMED unveils its innovative ATTC platform, potentially providing precision oncology with synergistic dual-mechanism of action — — Lead candidate HMPL-A251 harnesses a selective PI3K/PIKK inhibitor ...
Historic step in Indian medical education! Kozhikode Medical College becomes the first government institution to start an MD in Nuclear Medicine, revolutionising cancer care and diagnostics.